www.fdanews.com/articles/100703-ono-locus-ink-drug-discovery-agreement-on-kinases
Ono, Locus Ink Drug Discovery Agreement on Kinases
November 6, 2007
Japan’s Ono Pharmaceutical and Locus Pharmaceuticals have signed a new drug discovery agreement for a kinase target.
In July 2006, Ono and Locus entered a drug discovery collaboration targeting a kinase to discover and generate small molecule drug candidates.
Under the new agreement, Ono will have the sole responsibility for development and commercialization of resulting products. In addition to research funding, Locus will receive R&D milestone payments and royalties based on sales, Ono said.